AbbVie took the top spot with its acquisition of American biotech Nimble Therapeutics for $200 million. The pharma giant will get a hold of Nimble’s oral peptide IL23R inhibitor, which is currently in ...
Evaxion Biotech A/S announced the pricing of a public offering of 3,997,361 American Depositary Shares (ADSs) and accompanying warrants, priced at $2.71 per ADS. Notably, the MSD Global Health ...
European equities traded in the US as American depositary receipts were trending sharply higher late Wednesday morning, rising 1.36% to 1,375.76 on the S&P Europe Select ADR Index. From continental ...
Evaxion Biotech A/S announced that it has implemented a change in the ratio of its American Depositary Shares (ADSs) from one ADS representing ten ordinary shares to one ADS representing fifty ...
American Battery Materials, Inc. (OTC PINK:BLTH) (”ABM” or the “Company”), a U.S.-based renewable energy company focused on the extraction, refinement, and distribution of critical minerals in an ...